Company

WuXi AppTec Q3 Revenue Jumps 38% as Backlog Hits RMB 76.74 Billion – Full-Year Guidance Raised
Finanical ReportsHKG: 2359

WuXi AppTec Q3 Revenue Jumps 38% as Backlog Hits RMB 76.74 Billion – Full-Year Guidance Raised

WuXi AppTec Co., Ltd. (SHA: 603259; HKG: 2359) released its 2026 third-quarter report, posting Q3 operating revenue of RMB 16.640 billion, up 38.01% year on year (YoY), and net profit…

HutchMed's SANOVO Phase III Hits Primary Endpoint – ORPATHYS Plus TAGRISSO Extends Median PFS to 24.9 Months in MET-Overexpressing EGFR-Mutant NSCLC

HutchMed’s SANOVO Phase III Hits Primary Endpoint – ORPATHYS Plus TAGRISSO Extends Median PFS to 24.9 Months in MET-Overexpressing EGFR-Mutant NSCLC

Regeneron Extends BARDA Agreement With $270 Million Inmazeb Supply Deal for U.S. Ebola Preparedness Through 2031

Regeneron Extends BARDA Agreement With $270 Million Inmazeb Supply Deal for U.S. Ebola Preparedness Through 2031

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
MicroTech Medical Secures NMPA Approval for Equil Patch Insulin Pump in Children and Adolescents
DiabetesHKG: 2235

MicroTech Medical Secures NMPA Approval for Equil Patch Insulin Pump in Children and Adolescents

Biogen Receives FDA Complete‑Response Letter on High‑Dose Nusinersen for SMA
BiogenNASDAQ: BIIB

Biogen Receives FDA Complete‑Response Letter on High‑Dose Nusinersen for SMA

Eisai and Biogen Secure Australian TGA Approval for Lecanemab in Early Alzheimer’s Disease
BiogenNASDAQ: BIIB

Eisai and Biogen Secure Australian TGA Approval for Lecanemab in Early Alzheimer’s Disease

XtalPi and Bio‑Sincerity Announce AI‑Robotics R&D Partnership
AIBio‑Sincerity

XtalPi and Bio‑Sincerity Announce AI‑Robotics R&D Partnership

Show More